PIH Health Hospital - Whittier is a hospital in Whittier, California. It is a state-of-the-art facility with 548 licensed beds. Founded in 1959 as Presbyterian Intercommunity Hospital, it has been managed by the nonprofit InterHealth Corporation since the mid-1980s.

There are 548 beds in Presbyterian Intercommunity Hospital.

During the past decade, Presbyterian Intercommunity Hospital conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 20 clinical trials were completed, i.e. on average, 54.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 18 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presbyterian Intercommunity Hospital" #1 sponsor was "SWOG Cancer Research Network" with 22 trials, followed by "National Cancer Institute (NCI)" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Celcuity, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Intercommunity Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Intercommunity Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Presbyterian Intercommunity Hospital" in a lesser frequency.

Most popular intervention types in "Presbyterian Intercommunity Hospital" are "Drug" (40 trials), "Other" (34 trials), "Biological" (19 trials), "Procedure" (10 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (13 trials), "Docetaxel" (8 trials), "Questionnaire Administration" (8 trials) and "Nivolumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Intercommunity Hospital" are 44 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Presbyterian Intercommunity Hospital". undefined are not yet recruiting, 12 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Presbyterian Intercommunity Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Intercommunity Hospital, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Presbyterian Intercommunity Hospital has several departments that took part in Clinical trials: "Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital" - 6 trials, "Los Angeles Cardiology Associates" - 6 trials, "Agajanian Institute of Oncology and Hematology" - 2 trials, "PIH Health Hematology Medical Oncology" - 2 trials